DK105489D0 - Polypeptid - Google Patents

Polypeptid

Info

Publication number
DK105489D0
DK105489D0 DK105489A DK105489A DK105489D0 DK 105489 D0 DK105489 D0 DK 105489D0 DK 105489 A DK105489 A DK 105489A DK 105489 A DK105489 A DK 105489A DK 105489 D0 DK105489 D0 DK 105489D0
Authority
DK
Denmark
Prior art keywords
polypeptide
terminal end
heterologous protein
presentation
leader
Prior art date
Application number
DK105489A
Other languages
Danish (da)
English (en)
Inventor
Kjeld Norris
Fanny Norris
Soeren Bjoern
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26065137&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK105489(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK105489A priority Critical patent/DK105489D0/da
Publication of DK105489D0 publication Critical patent/DK105489D0/da
Priority claimed from DK494189A external-priority patent/DK494189D0/da
Priority to ZA901476A priority patent/ZA901476B/xx
Priority to AT90904258T priority patent/ATE110414T1/de
Priority to KR1019910701029A priority patent/KR970005928B1/ko
Priority to ES90904258T priority patent/ES2062514T5/es
Priority to CA002050336A priority patent/CA2050336C/en
Priority to PCT/DK1990/000058 priority patent/WO1990010075A1/en
Priority to JP2504527A priority patent/JP2609367B2/ja
Priority to EP90904258A priority patent/EP0461165B2/en
Priority to HU902376A priority patent/HU215538B/hu
Priority to UA5010019A priority patent/UA27706C2/uk
Priority to DE69011853T priority patent/DE69011853T3/de
Priority to DK90904258.2T priority patent/DK0461165T3/da
Priority to AU52612/90A priority patent/AU624694B2/en
Priority to SU5010019/13A priority patent/RU2194758C2/ru
Priority to NZ232742A priority patent/NZ232742A/xx
Priority to IE74990A priority patent/IE66469B1/en
Priority to PL90284146A priority patent/PL163532B1/pl
Priority to DD90338353A priority patent/DD296965A5/de
Priority to IL9360990A priority patent/IL93609A/en
Priority to CS901039A priority patent/CZ285239B6/cs
Priority to FI914125A priority patent/FI104985B/fi
Priority to NO913427A priority patent/NO304236B1/no
Priority to US08/196,887 priority patent/US5395922A/en
Priority to US08/397,595 priority patent/US5510249A/en
Priority to US08/397,597 priority patent/US5514585A/en
Priority to HU95P/P00592P priority patent/HU211600A9/hu
Priority to NO974899A priority patent/NO974899D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Processing Of Solid Wastes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK105489A 1989-01-06 1989-03-03 Polypeptid DK105489D0 (da)

Priority Applications (28)

Application Number Priority Date Filing Date Title
DK105489A DK105489D0 (da) 1989-03-03 1989-03-03 Polypeptid
ZA901476A ZA901476B (en) 1989-03-03 1990-02-27 A yeast processing system
AU52612/90A AU624694B2 (en) 1989-03-03 1990-03-01 Yeast processing system comprising a negatively charged amino acid adjacent to the processing site
SU5010019/13A RU2194758C2 (ru) 1989-03-03 1990-03-01 СПОСОБ ПОЛУЧЕНИЯ ГЕТЕРОЛОГИЧНОГО ПОЛИПЕПТИДА В ДРОЖЖАХ Saccharomyces cerevisiae
HU902376A HU215538B (hu) 1989-03-03 1990-03-01 Eljárás heterológ proteinek előállítására új élesztő kifejező rendszerrel
DK90904258.2T DK0461165T3 (da) 1989-03-03 1990-03-01 Gærspaltningssystem
NZ232742A NZ232742A (en) 1989-03-03 1990-03-01 Yeast heterologous protein production method, vectors, dna constructs and proteins so produced and aprotinin (1-58) so produced
ES90904258T ES2062514T5 (es) 1989-03-03 1990-03-01 Sistema de procesamiento de levadura que comprende un aminoacido cargado negativamente adyacente al sitio de procesamiento.
CA002050336A CA2050336C (en) 1989-03-03 1990-03-01 Yeast processing system comprising a negatively charged amino acid adjacent to the processing site
PCT/DK1990/000058 WO1990010075A1 (en) 1989-03-03 1990-03-01 Yeast processing system comprising a negatively charged amino acid adjacent to the processing site
JP2504527A JP2609367B2 (ja) 1989-03-03 1990-03-01 プロセッシング部位に隣接する負に帯電したアミノ酸からなる酵母プロセッシングシステム
EP90904258A EP0461165B2 (en) 1989-03-03 1990-03-01 Yeast processing system comprising a negatively charged amino acid adjacent to the processing site
KR1019910701029A KR970005928B1 (ko) 1989-03-03 1990-03-01 프라세싱 부위에 인접한 음전하를 띤 아미노산을 함유하는 이스트 프라세싱 시스템
UA5010019A UA27706C2 (uk) 1989-03-03 1990-03-01 Спосіб одержання гетерологічного поліпептиду
DE69011853T DE69011853T3 (de) 1989-03-03 1990-03-01 System zur bearbeitung von hefe, welches eine zur bearbeitungsstelle benachbarte negativ geladene aminosäure beeinhaltet.
AT90904258T ATE110414T1 (de) 1989-03-03 1990-03-01 System zur bearbeitung von hefe, welches eine zur bearbeitungsstelle benachbarte negativ geladene aminosäure beeinhaltet.
CS901039A CZ285239B6 (cs) 1989-03-03 1990-03-02 Polypeptid, konstrukce DNA, rekombinantní expresní vektor a způsob výroby heterologního polypeptidu a kmen kvasinek k tomuto účelu
IL9360990A IL93609A (en) 1989-03-03 1990-03-02 A polypeptide containing a yeast and amino acid processing site with a negative charge adjacent to it for yeast expression and a process to form a polypeptide or protein using the above polypeptide
IE74990A IE66469B1 (en) 1989-03-03 1990-03-02 Yeast processing system comprising a negatively charged amino acid adjacent to the processing site
DD90338353A DD296965A5 (de) 1989-03-03 1990-03-02 Hefeverarbeitungssystem
PL90284146A PL163532B1 (pl) 1989-03-03 1990-03-02 Sposób wytwarzania heterologicznych bialek lub polipeptydów PL PL PL PL PL PL PL
FI914125A FI104985B (fi) 1989-03-03 1991-09-02 Hiivan muokkausjärjestelmä, joka käsittää muokkauskohdan vieressä negatiivisesti varautuneen aminohapon
NO913427A NO304236B1 (no) 1989-03-03 1991-09-02 Polypeptid omfattende en sammensmelting av et signalpeptid, et lederpeptid og et heterologt protein eller polypeptid, DNA-konstruksjoner omfattende en DNA-sekvens som koder for polypeptidet samt gjµrstamme og vektor som kan uttrykke det
US08/196,887 US5395922A (en) 1989-03-03 1994-02-15 Yeast processing system
US08/397,595 US5510249A (en) 1989-01-06 1995-03-02 Yeast processing system
US08/397,597 US5514585A (en) 1989-01-06 1995-03-02 Yeast processing system
HU95P/P00592P HU211600A9 (en) 1989-03-03 1995-06-29 Yeast expressing system
NO974899A NO974899D0 (no) 1989-03-03 1997-10-23 Analogifremgangsmåte for fremstilling av en terapeutisk aktiv aprotinin-analog

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK105489A DK105489D0 (da) 1989-03-03 1989-03-03 Polypeptid
DK494189A DK494189D0 (da) 1989-10-06 1989-10-06 Polypeptid
PCT/DK1990/000058 WO1990010075A1 (en) 1989-03-03 1990-03-01 Yeast processing system comprising a negatively charged amino acid adjacent to the processing site

Publications (1)

Publication Number Publication Date
DK105489D0 true DK105489D0 (da) 1989-03-03

Family

ID=26065137

Family Applications (2)

Application Number Title Priority Date Filing Date
DK105489A DK105489D0 (da) 1989-01-06 1989-03-03 Polypeptid
DK90904258.2T DK0461165T3 (da) 1989-03-03 1990-03-01 Gærspaltningssystem

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK90904258.2T DK0461165T3 (da) 1989-03-03 1990-03-01 Gærspaltningssystem

Country Status (23)

Country Link
US (3) US5395922A (hu)
EP (1) EP0461165B2 (hu)
JP (1) JP2609367B2 (hu)
KR (1) KR970005928B1 (hu)
AT (1) ATE110414T1 (hu)
AU (1) AU624694B2 (hu)
CA (1) CA2050336C (hu)
CZ (1) CZ285239B6 (hu)
DD (1) DD296965A5 (hu)
DE (1) DE69011853T3 (hu)
DK (2) DK105489D0 (hu)
ES (1) ES2062514T5 (hu)
FI (1) FI104985B (hu)
HU (2) HU215538B (hu)
IE (1) IE66469B1 (hu)
IL (1) IL93609A (hu)
NO (2) NO304236B1 (hu)
NZ (1) NZ232742A (hu)
PL (1) PL163532B1 (hu)
RU (1) RU2194758C2 (hu)
UA (1) UA27706C2 (hu)
WO (1) WO1990010075A1 (hu)
ZA (1) ZA901476B (hu)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591603A (en) * 1987-08-28 1997-01-07 Novo Nordisk A/S Process for preparing aprotinin and aprotinin analogs in yeast cells
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
AU647025B2 (en) * 1989-05-19 1994-03-17 Biotechnology Research And Development Corporation Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification
GB9015825D0 (en) * 1990-07-18 1990-09-05 Ciba Geigy Ag In vitro processing of fusion proteins
DK300090D0 (da) * 1990-12-19 1990-12-19 Novo Nordisk As Fremgangsmaade til fremstilling af leadersekvenser
GB9106185D0 (en) * 1991-03-22 1991-05-08 Wellcome Found Biological control agents
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
FI92601C (fi) * 1992-03-11 1994-12-12 Marja Makarow Menetelmä hyötyproteiinien erittämiseksi hiivoista
US5521086A (en) * 1993-09-16 1996-05-28 Cephalon, Inc. Secretion sequence for the production of a heterologous protein in yeast
DE4417353A1 (de) * 1994-05-18 1996-01-25 Bayer Ag Verfahren zur Herstellung von rekombinantem Aprotinin und rekombinanten Aprotinin Varianten mit der natürlichen N-terminlaen Sequenz
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
IL114160A (en) * 1994-06-17 2006-12-31 Novo Nordisk As Dna constructs encoding heterologous proteins and processes for the heterologous protein production in yeast
US5861267A (en) * 1995-05-01 1999-01-19 Vertex Pharmaceuticals Incorporated Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity
ZA9610456B (en) * 1995-12-20 1997-06-20 Novo Nordisk As N-terminally extended proteins expressed in yeast
US5851800A (en) * 1996-05-14 1998-12-22 Pharmacia & Upjohn Ab Process for producing a protein
DE19629982A1 (de) 1996-07-25 1998-01-29 Bayer Ag Aprotinin-Varianten mit verbesserten Eigenschaften
EP1365028B1 (en) 1996-12-13 2009-03-18 Novartis Vaccines and Diagnostics, Inc. Method for expression of PDGF or IGF proteins in yeast
JP4187796B2 (ja) * 1996-12-20 2008-11-26 ノボ ノルディスク アクティーゼルスカブ 酵母で発現されたｎ末端伸長タンパク質
EP0954589A1 (en) * 1997-01-24 1999-11-10 Novo Nordisk A/S Synthetic leader peptide sequences
US6046000A (en) * 1997-11-07 2000-04-04 Millennium Biotherapeutics, Inc. Method for identifying genes encoding signal sequences
KR20010034305A (ko) 1998-01-23 2001-04-25 한센 핀 베네드 효모에서 원하는 폴리펩티드를 만드는 방법
AU1995701A (en) 1999-12-29 2001-07-16 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
US20030171267A1 (en) * 2000-04-12 2003-09-11 Rosen Craig A. Albumin fusion proteins
US7507413B2 (en) * 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
US7595172B2 (en) 2001-07-24 2009-09-29 Novo Nordisk A/S Method for making acylated polypeptides
EP1997829A1 (en) 2001-12-21 2008-12-03 Human Genome Sciences, Inc. Albumin fusion proteins
AU2002364587A1 (en) 2001-12-21 2003-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
CA2925807C (en) 2002-09-13 2020-09-15 Cornell Research Foundation, Inc. Using mutations to improve aspergillus phytases
EP1594530A4 (en) 2003-01-22 2006-10-11 Human Genome Sciences Inc HYBRID PROTEINS OF ALBUMIN
WO2005047508A1 (en) 2003-11-14 2005-05-26 Novo Nordisk A/S Processes for making acylated insulin
EP1692168B1 (en) 2003-12-03 2011-07-20 Novo Nordisk A/S Single-chain insulin
US9056921B2 (en) 2005-08-16 2015-06-16 Novo Nordisk A/S Method for making mature insulin polypeptides
ES2387955T3 (es) 2006-02-27 2012-10-04 Novo Nordisk A/S Derivados de insulina
US20080026376A1 (en) 2006-07-11 2008-01-31 Huaming Wang KEX2 cleavage regions of recombinant fusion proteins
US8198046B2 (en) 2006-07-11 2012-06-12 Danisco Us Inc. KEX2 cleavage regions of recombinant fusion proteins
BRPI0717098B8 (pt) 2006-09-22 2021-05-25 Novo Nordisk As análogos de insulina humana resistentes à protease, composição farmacêutica e processo para sua preparação
JP5503968B2 (ja) 2006-09-27 2014-05-28 ノボ・ノルデイスク・エー／エス 成熟インスリンポリペプチドの作製方法
WO2008062010A2 (en) 2006-11-22 2008-05-29 Novo Nordisk A/S Method for making activated carboxypeptidases
WO2009010428A1 (en) 2007-07-16 2009-01-22 Novo Nordisk A/S Protease stabilized, pegylated insulin analogues
US8575096B2 (en) 2007-08-13 2013-11-05 Novo Nordisk A/S Rapid acting insulin analogues
EP2708554A1 (en) 2007-08-15 2014-03-19 Novo Nordisk A/S Insulin analogues with an acyl and alkylene glycol moiety
EP2178910B1 (en) 2007-08-15 2014-10-08 Novo Nordisk A/S Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
US8501449B2 (en) * 2007-12-04 2013-08-06 Proteon Therapeutics, Inc. Recombinant elastase proteins and methods of manufacturing and use thereof
KR20110004366A (ko) 2008-03-18 2011-01-13 노보 노르디스크 에이/에스 프로테아제 안정화되고, 아실화된 인슐린 유사체
WO2009121884A1 (en) 2008-04-01 2009-10-08 Novo Nordisk A/S Insulin albumin conjugates
WO2011089170A2 (en) 2010-01-22 2011-07-28 Novo Nordisk A/S Process for preparing fgf-21 with low degree of o-glycosylation
AU2010223154B2 (en) * 2009-03-12 2014-10-09 Bigtec Private Limited A polynucleotide and polypeptide sequence and methods thereof
PL2612677T3 (pl) 2009-06-26 2015-10-30 Novo Nordisk As Preparat zawierający insulinę, nikotynamid i argininę
US8815541B2 (en) 2009-11-25 2014-08-26 Novo Nordisk A/S Method for making polypeptides
WO2011161124A1 (en) 2010-06-23 2011-12-29 Novo Nordisk A/S Insulin analogues containing additional disulfide bonds
CA2802510A1 (en) 2010-06-23 2011-12-29 Novo Nordisk A/S Insulin derivatives containing additional disulfide bonds
EP2585483A1 (en) 2010-06-23 2013-05-01 Novo Nordisk A/S Human insulin containing additional disulfide bonds
JP2013545782A (ja) 2010-12-14 2013-12-26 ノヴォ ノルディスク アー／エス 長時間作用型インスリンと組み合わせた速効型インスリン
EP2651446A1 (en) 2010-12-14 2013-10-23 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and an amino acid
CN103596584B (zh) 2011-06-15 2016-12-14 诺沃—诺迪斯克有限公司 多取代的胰岛素
RU2460795C1 (ru) * 2011-07-06 2012-09-10 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт генетики и селекции промышленных микроорганизмов" (ФГУП "ГосНИИгенетика") Способ микробиологического синтеза секретируемого соматотропина человека и штамм дрожжей saccharomyces cerevisiae - продуцент секретируемого соматотропина человека
WO2013186138A1 (en) 2012-06-14 2013-12-19 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and arginine
US9707276B2 (en) 2012-12-03 2017-07-18 Merck Sharp & Dohme Corp. O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues
CN103254277B (zh) 2013-05-03 2017-02-08 南京工业大学 强分泌性信号肽增强小肽模序及其应用
EP3004156A1 (en) 2013-06-07 2016-04-13 Novo Nordisk A/S Method for making mature insulin polypeptides
PL233560B1 (pl) 2014-12-05 2019-10-31 Mabion Spolka Akcyjna Sposób otrzymywania insuliny lub analogu insuliny z prekursora rekombinowanego białka
WO2016144658A1 (en) 2015-03-10 2016-09-15 Merck Sharp & Dohme Corp. Process for preparing recombinant insulin using microfiltration
ES2784603T3 (es) 2015-06-02 2020-09-29 Novo Nordisk As Insulinas con extensiones recombinantes polares
US20180244743A1 (en) 2015-08-25 2018-08-30 Novo Nordisk A/S Novel Insulin Derivatives and the Medical Uses Hereof
CN108026156A (zh) 2015-08-25 2018-05-11 诺和诺德股份有限公司 新型胰岛素衍生物及其医学用途
WO2017032798A1 (en) 2015-08-25 2017-03-02 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
KR102043067B1 (ko) * 2017-08-08 2019-11-11 엘지전자 주식회사 차량용 사이드 미러 및 차량
MA49896A (fr) 2017-08-17 2020-06-24 Novo Nordisk As Nouveaux analogues d'insuline acylés et leurs utilisations
FI4073097T3 (fi) 2019-12-11 2024-08-13 Novo Nordisk As Uusia insuliinianalogeja ja niiden käyttötapoja
WO2023144240A1 (en) 2022-01-26 2023-08-03 Novo Nordisk Research Centre Oxford Limited Glucose sensitive insulin derivatives and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5712580A (en) * 1979-04-05 1980-10-09 James Joseph Connell Engine charging and scavenging
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
JPS60501140A (ja) * 1983-04-22 1985-07-25 アムジエン 酵母による外因性ポリペプチドの分泌
US4588684A (en) * 1983-04-26 1986-05-13 Chiron Corporation a-Factor and its processing signals
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
JPS61264000A (ja) * 1985-03-21 1986-11-21 イミユネツクス　コ−ポレイシヨン 標識ペプチドによるタンパク質の合成
EP0206783A3 (en) * 1985-06-20 1988-10-05 The Salk Institute Biotechnology Industrial Associates, Inc. Expression and secretion of polypeptides from saccharomyces cerevisiae
MC1834A1 (fr) * 1986-07-10 1988-06-03 Transgene Sa Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation
US4987070A (en) * 1987-03-04 1991-01-22 Suntory Limited Use of a 97 amino acid leader sequence from the E. coli B-galactosidase gene for the production of hanp and hptc as fusion proteins
AU1987088A (en) * 1987-06-24 1989-01-19 Novo Nordisk A/S A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
DK450187D0 (da) * 1987-08-28 1987-08-28 Novo Industri As Fremgangsmaade til fremstilling af proteiner
DK463887D0 (da) * 1987-09-07 1987-09-07 Novo Industri As Gaerleader
JPH01240191A (ja) * 1988-02-16 1989-09-25 Green Cross Corp:The 酵母で機能する新規シグナルペプチドおよびこれを用いた異種蛋白質の分泌発現
DK336188D0 (da) * 1988-06-20 1988-06-20 Nordisk Gentofte Propeptider
JP3092811B2 (ja) * 1988-07-23 2000-09-25 デルタ バイオテクノロジー リミテッド ペプチドおよびｄｎａ配列
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid

Also Published As

Publication number Publication date
ZA901476B (en) 1990-11-28
DE69011853T3 (de) 1998-06-25
JPH04504846A (ja) 1992-08-27
US5514585A (en) 1996-05-07
IE66469B1 (en) 1995-12-27
CZ103990A3 (cs) 1999-03-17
DE69011853D1 (de) 1994-09-29
JP2609367B2 (ja) 1997-05-14
DK0461165T3 (da) 1994-11-21
NO974899L (no) 1997-10-23
US5510249A (en) 1996-04-23
UA27706C2 (uk) 2000-10-16
EP0461165A1 (en) 1991-12-18
HUT58370A (en) 1992-02-28
CZ285239B6 (cs) 1999-06-16
CA2050336C (en) 2000-01-18
NZ232742A (en) 1991-10-25
NO974899D0 (no) 1997-10-23
FI104985B (fi) 2000-05-15
DE69011853T2 (de) 1994-12-15
CA2050336A1 (en) 1990-09-04
KR970005928B1 (ko) 1997-04-22
HU215538B (hu) 1999-01-28
ATE110414T1 (de) 1994-09-15
AU5261290A (en) 1990-09-26
PL163532B1 (pl) 1994-04-29
DD296965A5 (de) 1991-12-19
HU211600A9 (en) 1995-12-28
RU2194758C2 (ru) 2002-12-20
IE900749L (en) 1990-09-03
ES2062514T3 (es) 1994-12-16
US5395922A (en) 1995-03-07
KR920701452A (ko) 1992-08-11
EP0461165B2 (en) 1998-03-25
FI914125A0 (fi) 1991-09-02
EP0461165B1 (en) 1994-08-24
IL93609A (en) 2001-11-25
WO1990010075A1 (en) 1990-09-07
NO304236B1 (no) 1998-11-16
HU902376D0 (en) 1991-11-28
IL93609A0 (en) 1990-12-23
ES2062514T5 (es) 1998-06-01
NO913427D0 (no) 1991-09-02
AU624694B2 (en) 1992-06-18
NO913427L (no) 1991-11-01

Similar Documents

Publication Publication Date Title
DK105489D0 (da) Polypeptid
ATE160587T1 (de) Expression rekombinanter polypeptide mit verbesserter möglichkeit zur reinigung
DK323587D0 (da) Protein
DE69435049D1 (de) Chimäre proteine zur vermeidung der komplementaktivierung
ZA8860B (en) Pancreatic secretory trypsin inhibitor and variants thereof produced by a recombinant host,process,expression vector and recombinant host therefor and pharmaceutical use thereof
DK114788A (da) Fremgangsmaade til fremstilling af et fysiologisk aktivt peptid
FI961238A (fi) Erityssekvenssi heterologisen proteiinin tuottamiseksi hiivassa
ATE317443T1 (de) N-terminal verlängerte proteine exprimiert in hefe
EP0210279A4 (en) STABILIZED HUMAN PROUROKINASE.
CA2198966A1 (en) Method for cleaving chimeric protein using processing enzyme
ATE141645T1 (de) In vitro-behandlung von fusionsproteinen
Bjorn et al. Yeast processing system

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
AHB Application shelved due to non-payment